Page last updated: 2024-08-18

pyrroles and technetium tc 99m medronate

pyrroles has been researched along with technetium tc 99m medronate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kunawudhi, A; Mahmood, U; Michaelson, MD; Palmer, EL; Saylor, PJ; Smith, MR	1

Trials

1 trial(s) available for pyrroles and technetium tc 99m medronate

Article	Year
Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:11 Topics: Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Humans; Indoles; Male; Molecular Targeted Therapy; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Radionuclide Imaging; Sunitinib; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Treatment Failure	2012

Article

Year

Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:11

Topics: Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Humans; Indoles; Male; Molecular Targeted Therapy; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Radionuclide Imaging; Sunitinib; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Treatment Failure

2012